tag:blogger.com,1999:blog-35997458635844014.post2206804455657690822..comments2023-04-09T09:54:31.911-04:00Comments on Cancer Stem Cell News: Targeting cancer stem cellsJim Tillhttp://www.blogger.com/profile/02092503335133096747noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-35997458635844014.post-45935948947775904262009-11-10T10:27:00.397-05:002009-11-10T10:27:00.397-05:00A Phase I trial is being conducted by Quantum Immu...A Phase I trial is being conducted by Quantum Immunologics, Inc. (QI). It's a <a href="http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=601189&protocolsearchid=6970976&version=patient" rel="nofollow">Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer</a>. Mentor Capital, Inc. is the largest single shareholder in QI. See: <a href="http://www.medicalnewstoday.com/articles/157788.php" rel="nofollow">Quantum Immunologics, A Major Mentor Capital Investee, Starts FDA-Authorized Breast Cancer Trials</a>, <em>Medical News Today</em>, July 16, 2009. The target is oncofetal antigen (OFA), not breast cancer stem cells.Jim Tillhttps://www.blogger.com/profile/02092503335133096747noreply@blogger.comtag:blogger.com,1999:blog-35997458635844014.post-13423670238844622612009-11-09T17:57:39.608-05:002009-11-09T17:57:39.608-05:00Mentor Capital is well poised to become a signific...Mentor Capital is well poised to become a significant participant in the expanding medical sector of Cancer Immunotherapy, an emerging approach to overcome the historic medical nemesis of Cancer. This is starting with MNTR's initial $2.2 million or 20% investment in Quantum Immunologics, Inc. (QI), a private company. The QI agreement contemplates "there is potential for significantly increased investment, or even merger of the Parties."<br /><br /><br />For More information:mentorcapital.com/$5-Share-Sr.-Securities-Analyst.htmlTroy Bhttps://www.blogger.com/profile/10331448069949780262noreply@blogger.com